IGF1R and hepatocellular carcinoma: Our results indicated that niclosamide can enhance sorafenib sensitivity in sorafenib-resistant HCC cells through the p-IGF-1R/insulin-like growth factor 1 receptor (IGF-1R)/stemness regulation and metabolic changes.